The board of directors of healthcare company Abbott (NYSE:ABT) approved a quarterly dividend of USD0.36 per share of the company's common stock, it declared on Friday.
In addition, the company has increased its dividend payout for 48 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.
This cash dividend is due on 15 May 2020 to shareholders of record at the close of business as of 15 April 2020.
Abbott said its portfolio of life-changing technologies covers all healthcare, with businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government